Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

NewAmsterdam Pharma Company N.V. Ordinary Shares

NAMS
Current price
17.82 USD +1.06 USD (+6.32%)
Last closed 17.02 USD
Company
ISIN unknown
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 1 737 296 896 USD
Yield for 12 month +72.67 %
1Y
3Y
5Y
10Y
15Y
NAMS
21.11.2021 - 28.11.2021

NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with metabolic disease. It is developing obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases. The company also develops Obicetrapib which is in Phase 2a clinical trial for Alzheimer's disease. NewAmsterdam Pharma Company N.V. is headquartered in Naarden, the Netherlands. Address: Gooimeer 2-35, Naarden, Netherlands, 1411 DC

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

37 USD

P/E ratio

Dividend Yield

Current Year

+12 762 722 USD

Last Year

+95 905 926 USD

Current Quarter

+2 127 446 USD

Last Quarter

+1 298 306 USD

Current Year

+12 718 328 USD

Last Year

+95 905 926 USD

Current Quarter

+2 109 708 USD

Last Quarter

+1 298 306 USD

Key Figures NAMS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -208 628 000 USD
Operating Margin TTM -2306.93 %
PE Ratio
Return On Assets TTM -27.15 %
PEG Ratio
Return On Equity TTM -54.08 %
Wall Street Target Price 37 USD
Revenue TTM 7 424 000 USD
Book Value 4.3 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 32.7 %
Dividend Yield
Gross Profit TTM
Earnings per share -2.62 USD
Diluted Eps TTM -2.62 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics NAMS

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History NAMS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:1
Payout Ratio
Last Split Date 23.11.2022
Dividend Date

Stock Valuation NAMS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 173.5247
Price Sales TTM 234.0109
Enterprise Value EBITDA 27.6291
Price Book MRQ 4.4353

Financials NAMS

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators NAMS

For 52 weeks

7.22 USD 26.35 USD
50 Day MA 17.01 USD
Shares Short Prior Month 442 964
200 Day MA 19.35 USD
Short Ratio 2.12
Shares Short 548 709
Short Percent 1.03 %